Company Overview of Naurex, Inc.
Naurex, Inc. is a biopharmaceutical company that is focused on the discovery, development, and commercialization of medicines for the treatment of psychiatric and neurologic disorders. Its platform discovers compounds that modulate the N-methyl-D-aspartate receptor that is important for normal brain and nervous system function. The company’s products include Rapastinel and NRX-1074 compounds for rapid and substantial reduction in depressive symptoms in subjects with major depressive disorder. Naurex, Inc. was founded in 2006 and is based in Evanston, Illinois. As of August 31, 2015, Naurex, Inc. operates as a subsidiary of Allergan plc.
1801 Maple Avenue
Evanston, IL 60201
Founded in 2006
Key Executives for Naurex, Inc.
Naurex, Inc. Key Developments
Similar Private Companies By Industry
|AntiOp, Inc.||United States|
|Aerpio Therapeutics, Inc.||United States|
|TRF Pharma, Inc.||United States|
|Longevity Biotech, Inc.||United States|
|AvantCare, Inc.||United States|
Recent Private Companies Transactions
July 26, 2015
To contact Naurex, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.